It is generally believed that the high expression of CD38 is associated with several hematological malignancies, which is an important feature of multiple myeloma and is also associated with B-cell chronic lymphoblastic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and acute promyelocytic leukemia [92]. This evidence concerns the gene CD38 and AL amyloidosis.